Literature DB >> 9579849

Assessing patients' needs and preferences in the management of advanced colorectal cancer.

K Redmond1.   

Abstract

Clinical decision-making in advanced cancer is a highly complex process. Many factors are thought to influence this process arguably the most important of these is the patient's own preference. Studies show that most patients want to be fully informed as to their diagnosis and involved in clinical decision-making. However, the attitudes of healthcare workers often preclude patient involvement. Studies have also shown that acceptability of chemotherapy for minimal therapeutic gain differs markedly between patients depending on factors such as age, gender and family status. It is clearly impossible to make decisions about what is best for patients without involving them in the decision-making process. Indeed, it could be argued that active patient participation actually simplifies this process.

Entities:  

Mesh:

Year:  1998        PMID: 9579849      PMCID: PMC2149720          DOI: 10.1038/bjc.1998.419

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Patient information as a necessary therapeutic intervention.

Authors:  G Grahn
Journal:  Eur J Cancer Care (Engl)       Date:  1996-03       Impact factor: 2.520

2.  Tradeoffs between quality and quantity of life: development of the QQ Questionnaire for Cancer Patient Attitudes.

Authors:  A M Stiggelbout; J C de Haes; G M Kiebert; J Kievit; J W Leer
Journal:  Med Decis Making       Date:  1996 Apr-Jun       Impact factor: 2.583

3.  Effects of framing and level of probability on patients' preferences for cancer chemotherapy.

Authors:  A M O'Connor
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

4.  Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer.

Authors:  B Glimelius; K Hoffman; W Graf; U Haglund; O Nyrén; L Påhlman; P O Sjödén
Journal:  Ann Oncol       Date:  1995-03       Impact factor: 32.976

5.  Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer.

Authors:  B J McNeil; R Weichselbaum; S G Pauker
Journal:  N Engl J Med       Date:  1981-10-22       Impact factor: 91.245

6.  Information and participation preferences among cancer patients.

Authors:  B R Cassileth; R V Zupkis; K Sutton-Smith; V March
Journal:  Ann Intern Med       Date:  1980-06       Impact factor: 25.391

7.  Fallacy of the five-year survival in lung cancer.

Authors:  B J McNeil; R Weichselbaum; S G Pauker
Journal:  N Engl J Med       Date:  1978-12-21       Impact factor: 91.245

8.  Information and decision-making preferences of hospitalized adult cancer patients.

Authors:  C G Blanchard; M S Labrecque; J C Ruckdeschel; E B Blanchard
Journal:  Soc Sci Med       Date:  1988       Impact factor: 4.634

9.  Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.

Authors:  T G Allen-Mersh; S Earlam; C Fordy; K Abrams; J Houghton
Journal:  Lancet       Date:  1994-11-05       Impact factor: 79.321

10.  Cancer patients: their desire for information and participation in treatment decisions.

Authors:  H J Sutherland; H A Llewellyn-Thomas; G A Lockwood; D L Tritchler; J E Till
Journal:  J R Soc Med       Date:  1989-05       Impact factor: 18.000

View more
  4 in total

1.  Variation in the provision of chemotherapy for colorectal cancer.

Authors:  A McLeod
Journal:  J Epidemiol Community Health       Date:  1999-12       Impact factor: 3.710

2.  Measuring women's preferences for breast cancer treatments and BRCA1/BRCA2 testing.

Authors:  M Cappelli; L Surh; L Humphreys; S Verma; D Logan; A Hunter; J Allanson
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

Review 3.  Palliative chemotherapy for advanced or metastatic colorectal cancer. Colorectal Meta-analysis Collaboration.

Authors: 
Journal:  Cochrane Database Syst Rev       Date:  2000

4.  The survival impact of palliative chemotherapy dose modifications on metastatic colon cancer.

Authors:  Mohd Naqib Zainal Abidin; Marhanis Salihah Omar; Farida Islahudin; Noraida Mohamed Shah
Journal:  BMC Cancer       Date:  2022-07-04       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.